A New Tool to Help Doctors Tell Type 1 Diabetes Apart from MODY

Type 1 diabetes and MODY (maturity-onset diabetes of the young) are both genetic forms of diabetes that require insulin treatment, but they are very different conditions. MODY is caused by a single gene mutation, while Type 1 diabetes involves multiple genetic factors and typically an autoimmune process. Getting the right diagnosis is important because it affects how doctors monitor and manage the condition.

The challenge: when a patient comes in needing insulin, doctors often don't know immediately whether they have Type 1 diabetes or MODY. Genetic testing for MODY can be expensive and time-consuming, especially when the real answer is Type 1 diabetes.

Researchers studied 1,129 insulin-treated patients who were referred for MODY genetic testing. All participants had their DNA tested for 10 genetic variants used to calculate a Type 1 diabetes genetic risk score.

The results showed that among patients whose MODY genetic testing did not find a diagnosis (called 'genetically unsolved MODY'), about 26% likely had Type 1 diabetes instead. This percentage varied significantly by age: 76.2% of children in this group probably had Type 1 diabetes, compared to just 16.8% of adults.

In contrast, patients who were successfully diagnosed with MODY through genetic testing did not show signs of elevated Type 1 diabetes genetic risk, suggesting the risk score correctly distinguished between the two conditions.

The researchers explored whether the T1DGRS could be used before genetic testing to predict who actually has Type 1 diabetes versus MODY. This could potentially save time and money by avoiding unnecessary MODY testing.

The results were mixed. Overall, the score's ability to separate Type 1 diabetes from MODY was modest. However, in children specifically, the tool performed much better—it could have avoided about half of MODY genetic tests in children without missing any actual MODY diagnoses. In adults, the score was less useful as a pre-test screening tool.

This research suggests that including a Type 1 diabetes genetic risk score in standard MODY gene panel testing could help doctors better understand which patients truly have Type 1 diabetes. This is particularly valuable for young patients, where the distinction can be clearer.

The findings don't mean the score can replace genetic testing—it's a tool to help guide decisions. For patients and families, this work highlights why genetic testing can be so valuable: a more accurate diagnosis helps ensure the right monitoring and management for the specific type of diabetes someone has.

Source: Diabetes care. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.